NM_015386.3:c.1195+8C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015386.3(COG4):​c.1195+8C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00594 in 1,613,914 control chromosomes in the GnomAD database, including 520 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.032 ( 284 hom., cov: 31)
Exomes 𝑓: 0.0033 ( 236 hom. )

Consequence

COG4
NM_015386.3 splice_region, intron

Scores

2
Splicing: ADA: 0.00004054
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.613

Publications

1 publications found
Variant links:
Genes affected
COG4 (HGNC:18620): (component of oligomeric golgi complex 4) The protein encoded by this gene is a component of an oligomeric protein complex involved in the structure and function of the Golgi apparatus. Defects in this gene may be a cause of congenital disorder of glycosylation type IIj. Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Aug 2010]
COG4 Gene-Disease associations (from GenCC):
  • COG4-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, ClinGen, PanelApp Australia, Ambry Genetics
  • microcephalic osteodysplastic dysplasia, Saul-Wilson type
    Inheritance: AD, AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 16-70500950-G-A is Benign according to our data. Variant chr16-70500950-G-A is described in ClinVar as Benign. ClinVar VariationId is 320375.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.107 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COG4NM_015386.3 linkc.1195+8C>T splice_region_variant, intron_variant Intron 9 of 18 ENST00000323786.10 NP_056201.2 Q9H9E3J3KNI1Q8N8L9
COG4NM_001195139.2 linkc.1183+8C>T splice_region_variant, intron_variant Intron 9 of 17 NP_001182068.2 Q9H9E3A0A0A0MS45Q8N8L9
COG4NM_001365426.1 linkc.769+8C>T splice_region_variant, intron_variant Intron 10 of 19 NP_001352355.1
COG4NR_158212.1 linkn.1206+8C>T splice_region_variant, intron_variant Intron 9 of 18

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COG4ENST00000323786.10 linkc.1195+8C>T splice_region_variant, intron_variant Intron 9 of 18 1 NM_015386.3 ENSP00000315775.5 J3KNI1

Frequencies

GnomAD3 genomes
AF:
0.0317
AC:
4822
AN:
152080
Hom.:
284
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.110
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0111
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000426
Gnomad OTH
AF:
0.0244
GnomAD2 exomes
AF:
0.00792
AC:
1991
AN:
251408
AF XY:
0.00617
show subpopulations
Gnomad AFR exome
AF:
0.108
Gnomad AMR exome
AF:
0.00382
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000290
Gnomad OTH exome
AF:
0.00521
GnomAD4 exome
AF:
0.00326
AC:
4769
AN:
1461716
Hom.:
236
Cov.:
31
AF XY:
0.00292
AC XY:
2125
AN XY:
727172
show subpopulations
African (AFR)
AF:
0.112
AC:
3755
AN:
33474
American (AMR)
AF:
0.00436
AC:
195
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26136
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39690
South Asian (SAS)
AF:
0.00174
AC:
150
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53314
Middle Eastern (MID)
AF:
0.00243
AC:
14
AN:
5768
European-Non Finnish (NFE)
AF:
0.000194
AC:
216
AN:
1111962
Other (OTH)
AF:
0.00719
AC:
434
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
221
443
664
886
1107
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
122
244
366
488
610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0317
AC:
4825
AN:
152198
Hom.:
284
Cov.:
31
AF XY:
0.0309
AC XY:
2302
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.110
AC:
4563
AN:
41496
American (AMR)
AF:
0.0111
AC:
169
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5190
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10602
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000426
AC:
29
AN:
68028
Other (OTH)
AF:
0.0265
AC:
56
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
209
417
626
834
1043
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0148
Hom.:
83
Bravo
AF:
0.0350
Asia WGS
AF:
0.0180
AC:
61
AN:
3478
EpiCase
AF:
0.000273
EpiControl
AF:
0.000356

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Feb 23, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

COG4-related disorder Benign:1
Jan 22, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

COG4-congenital disorder of glycosylation Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.78
DANN
Benign
0.38
PhyloP100
-0.61
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000041
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs80034177; hg19: chr16-70534853; API